Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection.

Li Y, Wei C, Xu H, Jia J, Wei Z, Guo R, Jia Y, Wu Y, Li Y, Qi X, Li Z, Gao X.

Mediators Inflamm. 2018 Mar 19;2018:6587296. doi: 10.1155/2018/6587296. eCollection 2018. Review.

2.

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Ferretti E, Di Carlo E, Ognio E, Fraternali-Orcioni G, Corcione A, Belmonte B, Ravetti JL, Tripodo C, Ribatti D, Pistoia V.

Oncoimmunology. 2017 Nov 27;7(3):e1397249. doi: 10.1080/2162402X.2017.1397249. eCollection 2018.

PMID:
29399397
3.

Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.

Monin L, Gaffen SL.

Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4). pii: a028522. doi: 10.1101/cshperspect.a028522. Review.

4.

Cytokines TNF-α, IL-6, IL-17F, and IL-4 Differentially Affect Osteogenic Differentiation of Human Adipose Stem Cells.

Bastidas-Coral AP, Bakker AD, Zandieh-Doulabi B, Kleverlaan CJ, Bravenboer N, Forouzanfar T, Klein-Nulend J.

Stem Cells Int. 2016;2016:1318256. doi: 10.1155/2016/1318256. Epub 2016 Sep 7.

5.

Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer.

Bie Q, Sun C, Gong A, Li C, Su Z, Zheng D, Ji X, Wu Y, Guo Q, Wang S, Xu H.

Sci Rep. 2016 May 5;6:25447. doi: 10.1038/srep25447.

6.

The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity.

Song X, He X, Li X, Qian Y.

Cell Mol Immunol. 2016 Jul;13(4):418-31. doi: 10.1038/cmi.2015.105. Epub 2016 Mar 28. Review.

7.

Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.

Liu S, Zhang Q, Chen C, Ge D, Qu Y, Chen R, Fan YM, Li N, Tang WW, Zhang W, Zhang K, Wang AR, Rowan BG, Hill SM, Sartor O, Abdel-Mageed AB, Myers L, Lin Q, You Z.

Oncotarget. 2016 Mar 22;7(12):13651-66. doi: 10.18632/oncotarget.7296.

8.

Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation.

Reynolds JM, Lee YH, Shi Y, Wang X, Angkasekwinai P, Nallaparaju KC, Flaherty S, Chang SH, Watarai H, Dong C.

Immunity. 2015 Apr 21;42(4):692-703. doi: 10.1016/j.immuni.2015.03.008. Epub 2015 Apr 14.

9.

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.

Wu HH, Hwang-Verslues WW, Lee WH, Huang CK, Wei PC, Chen CL, Shew JY, Lee EY, Jeng YM, Tien YW, Ma C, Lee WH.

J Exp Med. 2015 Mar 9;212(3):333-49. doi: 10.1084/jem.20141702. Epub 2015 Mar 2.

10.

Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B, Javorhazy A, Sumegi K, Banfai Z, Melegh B.

World J Orthop. 2014 Sep 18;5(4):516-36. doi: 10.5312/wjo.v5.i4.516. eCollection 2014 Sep 18. Review.

11.

Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock.

Shimura E, Shibui A, Narushima S, Nambu A, Yamaguchi S, Akitsu A, Leonard WJ, Iwakura Y, Matsumoto K, Suto H, Okumura K, Sudo K, Nakae S.

Biochem Biophys Res Commun. 2014 Oct 10;453(1):1-6. doi: 10.1016/j.bbrc.2014.09.004. Epub 2014 Sep 6.

12.

Role of Interleukin-17 in defense against pseudomonas aeruginosa infection in lungs.

Xu X, Shao B, Wang R, Zhou S, Tang Z, Lu W, Xiong S.

Int J Clin Exp Med. 2014 Apr 15;7(4):809-16. eCollection 2014.

13.

Potential involvement of IL-17F in asthma.

Ota K, Kawaguchi M, Matsukura S, Kurokawa M, Kokubu F, Fujita J, Morishima Y, Huang SK, Ishii Y, Satoh H, Hizawa N.

J Immunol Res. 2014;2014:602846. doi: 10.1155/2014/602846. Epub 2014 Apr 14. Review.

14.

Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility.

Magyari L, Kovesdi E, Sarlos P, Javorhazy A, Sumegi K, Melegh B.

World J Gastroenterol. 2014 Mar 28;20(12):3208-22. doi: 10.3748/wjg.v20.i12.3208. Review.

15.

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.

Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, Belkadi A, Picard C, Abel L, Fieschi C, Puel A, Li X, Casanova JL.

Immunity. 2013 Oct 17;39(4):676-86. doi: 10.1016/j.immuni.2013.09.002. Epub 2013 Oct 10.

16.

Codon optimization, expression, purification, and functional characterization of recombinant human IL-25 in Pichia pastoris.

Liu Y, Wu C, Wang J, Mo W, Yu M.

Appl Microbiol Biotechnol. 2013 Dec;97(24):10349-58. doi: 10.1007/s00253-013-5264-4. Epub 2013 Oct 8.

17.

IL-17 family: cytokines, receptors and signaling.

Gu C, Wu L, Li X.

Cytokine. 2013 Nov;64(2):477-85. doi: 10.1016/j.cyto.2013.07.022. Epub 2013 Sep 3. Review.

18.

Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients.

Lechner CJ, Grüner B, Huang X, Hoffmann WH, Kern P, Soboslay PT.

Clin Dev Immunol. 2012;2012:735342. doi: 10.1155/2012/735342. Epub 2012 Aug 30.

19.

The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings.

Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB.

J Invest Dermatol. 2013 Jan;133(1):17-26. doi: 10.1038/jid.2012.194. Epub 2012 Jun 7. Review.

20.

IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils.

Tosello Boari J, Amezcua Vesely MC, Bermejo DA, Ramello MC, Montes CL, Cejas H, Gruppi A, Acosta Rodríguez EV.

PLoS Pathog. 2012;8(4):e1002658. doi: 10.1371/journal.ppat.1002658. Epub 2012 Apr 26.

Supplemental Content

Support Center